NCT05116605

Brief Summary

The objective of this research study is to assess how the implementation of photobiomodulation affects sleep quality, sleep structure, nocturnal physiology, subjective wellness, recovery from stressors, and resultant effects on performance and well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2021

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

October 29, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2023

Completed
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

October 29, 2021

Last Update Submit

April 22, 2025

Conditions

Keywords

PhotobiomodulationSleepWearable Technology

Outcome Measures

Primary Outcomes (10)

  • Change in Nocturnal Heart Rate as measured by OURA Ring

    Heart rate (beats per minute) will be quantified throughout the night via the OURA ring.

    Daily from baseline through study completion at 8 weeks

  • Change in Subjective Sleep Quality

    A custom daily morning questionnaire will be used to record how a participant feels the quality of their sleep was the previous night (e.g. 1, very poor; 10 excellent). This questionnaire will be taken on the participants smartphone within 30 minutes of waking.

    Daily from baseline through study completion at 8 weeks

  • Change in Nocturnal Heart Rate Variability as measured by OURA Ring

    Heart rate variability will be quantified throughout the night via the OURA ring.

    Daily from baseline through study completion at 8 weeks

  • Subjective Success of PBM assessed via Survey

    Following completion of the study, a custom questionnaire will record how successful the participant believes PBM was in improving their sleep and well being.

    Once at the end of week 8

  • Changes in Subjective Anxiety as measured via the STAI

    Participants will complete the previously validated State Trait Anxiety Index (STAI) as a measure of subjective anxiety, where higher scores are suggestive of greater anxiety.

    Monthly from baseline through study completion at 8 weeks

  • Changes in Subjective Sleep as measured via PSQI

    Participant's subjective reports of sleep quality will be quantified through the previously validated Pittsburgh Sleep Quality Index (PSQI). Questions are scored into multiple components to determine sleep difficulty in various areas, where higher scores are indicative of greater sleep difficulties; these scores will be compared across timepoints.

    Monthly from baseline through study completion at 8 weeks

  • Changes in Perceived Stress as measured via PSS

    Participants' perceived stress will be quantified via the previously validated Perceived Stress Scale (PSS), which asks participants to report on the frequency of various experiences (0, never; 4, very often) and final scoring suggests lower scores to be associated with lower levels of stress.

    Weekly from baseline through study completion at 8 weeks

  • Change in Subjective Epworth Sleepiness Scale measured via questionnaire

    Participants will complete previously validated questionnaires as often as weekly. Epworth Sleepiness Scale (ESS) - eight-item questionnaire assessing sleep behaviors on a scale of 0 to 3. Higher scores = increased average sleep propensity in daily life

    Weekly throughout study completion at 8 weeks

  • Change in Eriksen Flanker Task

    The Flanker Task is a response inhibition test used to assess the participant's ability to suppress a response that is inappropriate based on the task rules. Participants are to respond, left or right, to the direction of the middle arrow (target arrow) of five aligned items. The task consists of congruent stimulus (the direction of the target arrow and flanker arrows are the same), incongruent stimulus (the direction of the target arrow is opposite of the flanker arrows), and neutral stimulus (flanker items are different then the target arrow). The dependent variable is the measurement of reaction time to select the direction of the target arrow.

    Changes from baseline versus end of study week 8

  • Change in Psychomotor Vigilance Task

    A reaction time test that measures a person's sustained attention to a cue presented on a screen at random inter-stimulus intervals. In addition to the measures of reaction time to correct responses the errors of commission (responding when there is not response cue) and omission (failing to respond to a response cue).

    Changes from baseline versus end of study week 8

Secondary Outcomes (2)

  • Change in Subjective Restorative Sleep Questionnaire

    Weekly throughout study completion at 8 weeks

  • Changes in Sleep Disturbances as measured via the Sleep Disorders Questionnaire

    Monthly from baseline through study completion at 8 weeks

Study Arms (1)

Photobiomodulation (PBM)

EXPERIMENTAL

Participants will utilize the NovoTHOR whole body light pod

Other: Photobiomodulation (PBM)

Interventions

Photobiomodulation (PBM) is light therapy in both the visible and near-infrared range (non-UV). This light is absorbed through the skin and functions at the cellular level, providing a lowering of inflammation and oxidative stress. Participants will undergo 20 minute sessions three times a week for 4 weeks using the NovoTHOR as the only intervention.

Also known as: NovoTHOR Whole Body Light Bed
Photobiomodulation (PBM)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female 18-50 years of age

You may not qualify if:

  • Has a head diameter outside the range of 20.8-24 inches, or an approved head-mounted EEG device doesn't otherwise fit properly
  • Exceeds 290 pounds in body weight
  • Has photophobia (light sensitivity)
  • Has epilepsy or is prone to seizures
  • Has thyroid problems or has been medicated for thyroid issues
  • Has a current lower body musculoskeletal injury
  • Has a current injury requiring an irremovable cast
  • Is pregnant or actively trying to become pregnant
  • Has a known or diagnosed sleep disorder
  • Females who have become menopausal or are exhibiting signs or symptoms of becoming perimenopausal
  • Females who are unable to identify when their monthly menstrual period will occur
  • Individuals who work during the night shift or have significantly abnormal sleep schedule
  • Has undergone travel across more than two collective time zones in the last two weeks
  • Individuals who intend to have any significant medical procedures scheduled to occur within 12 weeks of enrollment
  • Individuals who have intentions, or have discussed with their doctor, about adding or making any alterations to their prescribed medications within 12 weeks of enrollment
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rockefeller Neuroscience Institute at West Virginia University

Morgantown, West Virginia, 26505, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: All participants will complete the following design. Women who experience menstrual flow will be scheduled to ensure that flow occurs on weeks 4 \& 8 for consistency. Baseline block (weeks 1-4): At intake, participants will complete up to 13 surveys, which includes 2 baseline questionnaires, \& the first rendition of weekly \& monthly surveys, as well as complete a physical performance task \& 4 cognitive tasks. Participants will complete daily surveys each morning \& night, \& wear wearable devices to monitor physiology during sleep. A laboratory visit will occur once per week for completion of weekly surveys, as well as cognitive \& physical performance assessments; monthly surveys will also be completed during the fourth week. Intervention block (weeks 5-8): Daily, weekly, \& monthly activities described for the baseline block will continue; participants will additionally complete three 20-minute PBM sessions per week. The final week of this block will also involve an exit survey.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2021

First Posted

November 11, 2021

Study Start

October 25, 2021

Primary Completion

November 1, 2022

Study Completion

July 20, 2023

Last Updated

April 25, 2025

Record last verified: 2025-04

Locations